A carregar...

Comparing the long‐term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease‐modifying antirheumatic drug in patients with inflammatory polyarthritis

OBJECTIVE: To compare the clinical and functional outcome at 2 and 5 years in patients with inflammatory polyarthritis treated with either methotrexate (MTX) or sulfasalazine (SSZ) as the first disease‐modifying antirheumatic drug (DMARD). METHODS: Patients recruited to a primary‐care‐based inceptio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hider, S L, Silman, A, Bunn, D, Manning, S, Symmons, D, Lunt, M
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2006
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798363/
https://ncbi.nlm.nih.gov/pubmed/16540547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.049775
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!